High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use-Reference-Cited by-同舟云学术

High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

Published:2022-09 Issue:3 Volume:85 Page:322-326
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Gonzalez-Serna Alejandro,Macias Juan,Corma-Gomez Anaïs,Tellez Francisco,Cucurull Josep,Real Luis M^ORCID,Granados Rafael,Rivero-Juarez Antonio^ORCID,Hernandez-Quero José,Merino Dolores,Palacios Rosario,Rios Maria José,Collado Antonio,Pineda Juan A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference29 articles.

1. WHO (World Health Organization). Combating hepatitis B and C to reach elimination by 2030. Available at: https://www.whoint/hepatitis/publications/hep-elimination-by-2030-brief/en/2016. Last access: 232/6/2022.

2. Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain;Gonzalez-Serna;HIV Med,2021

3. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review;Degenhardt;Lancet Glob Health,2017

4. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study;Trickey;Lancet Gastroenterol Hepatol,2019

5. Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting;Socias;Liver Int,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice;Journal of Antimicrobial Chemotherapy;2023-09-06

2. Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study;Hepatitis Monthly;2023-04-15

3. Glecaprevir/pibrentasvir;Reactions Weekly;2022-08-27